Comparison of Onclarity Human Papillomavirus (HPV) Assay with Hybrid Capture II HPV DNA Assay for Detection of Cervical Intraepithelial Neoplasia Grade 2 and 3 Lesions.
about
HPV-Testing in Follow-up of Patients Treated for CIN2+ LesionsThe BD Onclarity HPV Assay on Samples Collected in SurePath Medium Meets the International Guidelines for Human Papillomavirus Test Requirements for Cervical Screening.High risk human papillomavirus prevalence and genotype distribution among women infected with HIV in Manaus, Amazonas.Validation of a Human Papillomavirus (HPV) DNA Cervical Screening Test That Provides Expanded HPV Typing.
P2860
Comparison of Onclarity Human Papillomavirus (HPV) Assay with Hybrid Capture II HPV DNA Assay for Detection of Cervical Intraepithelial Neoplasia Grade 2 and 3 Lesions.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Comparison of Onclarity Human ...... oplasia Grade 2 and 3 Lesions.
@ast
Comparison of Onclarity Human ...... oplasia Grade 2 and 3 Lesions.
@en
type
label
Comparison of Onclarity Human ...... oplasia Grade 2 and 3 Lesions.
@ast
Comparison of Onclarity Human ...... oplasia Grade 2 and 3 Lesions.
@en
prefLabel
Comparison of Onclarity Human ...... oplasia Grade 2 and 3 Lesions.
@ast
Comparison of Onclarity Human ...... oplasia Grade 2 and 3 Lesions.
@en
P2093
P2860
P50
P356
P1476
Comparison of Onclarity Human ...... oplasia Grade 2 and 3 Lesions.
@en
P2093
M T Sandri
S Carinelli
S Igidbashian
P2860
P304
P356
10.1128/JCM.00246-15
P407
P577
2015-04-22T00:00:00Z